124 related articles for article (PubMed ID: 17301555)
1. [Participation in the international multi-countries study-operational issues from company view point].
Hada S
Gan To Kagaku Ryoho; 2007 Feb; 34(2):324-7. PubMed ID: 17301555
[TBL] [Abstract][Full Text] [Related]
2. [Operational aspect of participation in the multi-national clinical trials from the foreign pharmaceutical company's standpoint].
Namazu K
Gan To Kagaku Ryoho; 2007 Feb; 34(2):328-30. PubMed ID: 17301556
[TBL] [Abstract][Full Text] [Related]
3. [Our policy and future tasks related to ICH in anti-cancer drug development--a discussion from the viewpoint of an enterprise].
Ekimoto H
Gan To Kagaku Ryoho; 1997 Jan; 24(2):229-37. PubMed ID: 9030236
[TBL] [Abstract][Full Text] [Related]
4. [Why multi-national clinical trials now?--Industry perspective].
Miki S
Gan To Kagaku Ryoho; 2007 Feb; 34(2):293-6. PubMed ID: 17301547
[TBL] [Abstract][Full Text] [Related]
5. [Participation to international registration trials--from the investigator's standpoint].
Ohtsu A
Gan To Kagaku Ryoho; 2007 Feb; 34(2):297-300. PubMed ID: 17301548
[TBL] [Abstract][Full Text] [Related]
6. [Globalization of clinical trials].
Akaza H; Fukuoka M; Ohtsu A; Usami M; Ikeda T; Aiba K; Isonishi S; Ohashi Y; Saijo N; Sone S; Tsukagoshi S; Tsuruo T; Kato M; Mikami O; Dong RP; von Euler M; Blackledge G; Stribling D
Gan To Kagaku Ryoho; 2003 Apr; 30(4):555-65. PubMed ID: 12722692
[TBL] [Abstract][Full Text] [Related]
7. [Contact and dialogue between drug companies and the global regulatory authorities throughout research and development phase].
Kock M; Thomsen MK
Ugeskr Laeger; 2003 Apr; 165(16):1649-52. PubMed ID: 12756820
[TBL] [Abstract][Full Text] [Related]
8. Current status and problems in development of molecular target agents for gastrointestinal malignancy in Japan.
Boku N
Jpn J Clin Oncol; 2010 Mar; 40(3):183-7. PubMed ID: 20047861
[TBL] [Abstract][Full Text] [Related]
9. Challenges in the clinical development requirements for the marketing authorization of new medicines in southeast Asia.
Kudrin A
J Clin Pharmacol; 2009 Mar; 49(3):268-80. PubMed ID: 19168433
[TBL] [Abstract][Full Text] [Related]
10. Performing phase I clinical trials of anticancer agents: perspectives from within the European union and Japan.
Forster MD; Saijo N; Seymour L; Calvert H
Clin Cancer Res; 2010 Mar; 16(6):1737-44. PubMed ID: 20215555
[TBL] [Abstract][Full Text] [Related]
11. APEC Harmonization Center: challenges and issues relating to multiregional clinical trials in the APEC region.
Park KL; Kim TG; Seong SK; Lee SY; Kim SH
Clin Pharmacol Ther; 2012 Apr; 91(4):743-6. PubMed ID: 22318621
[TBL] [Abstract][Full Text] [Related]
12. [International clinical trials for a medical oncologist in Japan].
Nakagawa K
Gan To Kagaku Ryoho; 2007 Feb; 34(2):320-3. PubMed ID: 17301554
[TBL] [Abstract][Full Text] [Related]
13. India's growing participation in global clinical trials.
Gupta YK; Padhy BM
Trends Pharmacol Sci; 2011 Jun; 32(6):327-9. PubMed ID: 21489644
[TBL] [Abstract][Full Text] [Related]
14. [Participation in the global study. Activities and issues from the bedside].
Yamamoto N
Gan To Kagaku Ryoho; 2007 Feb; 34(2):316-9. PubMed ID: 17301553
[TBL] [Abstract][Full Text] [Related]
15. [Current and future views from pharmaceutical industry perspectives on development of antidepressants].
Arano I; Imaeda T
Nihon Shinkei Seishin Yakurigaku Zasshi; 2011 Aug; 31(4):181-6. PubMed ID: 21941853
[TBL] [Abstract][Full Text] [Related]
16. Association between pharmaceutical involvement and outcomes in breast cancer clinical trials.
Peppercorn J; Blood E; Winer E; Partridge A
Cancer; 2007 Apr; 109(7):1239-46. PubMed ID: 17326054
[TBL] [Abstract][Full Text] [Related]
17. [How to plan and execute multinational clinical studies properly-management of ethnic differences, private information, and genetic testing].
Iwasaki M
Gan To Kagaku Ryoho; 2010 May; 37(5):771-6. PubMed ID: 20495304
[TBL] [Abstract][Full Text] [Related]
18. Clinical setbacks for toll-like receptor 9 agonists in cancer.
Schmidt C
Nat Biotechnol; 2007 Aug; 25(8):825-6. PubMed ID: 17687345
[No Abstract] [Full Text] [Related]
19. [The progress of second-line chemotherapy and molecular targeting agents in gastric cancer].
Takiuchi H
Gan To Kagaku Ryoho; 2009 May; 36(5):717-20. PubMed ID: 19461169
[TBL] [Abstract][Full Text] [Related]
20. [Current problems of early phase clinical trials for new anticancer agents in Japan].
Nakagawa K; Fukuoka M
Gan To Kagaku Ryoho; 2000 Jun; 27(6):925-9. PubMed ID: 10897223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
